ProQR Therapeutics N.V. (PRQR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 2.07M | 4.64M | 2.92M | 3.82M | 4.52M | 4.31M | 3.84M | 6.3M | 4.45M | 3.28M | 1.37M | 1.24M |
| Revenue Growth % | -54.27% | 7.83% | -24.15% | -39.46% | 1.55% | 31.15% | 180.51% | 407.24% | 538.45% | 171.18% | 54.28% | 20.8% |
| Cost of Goods Sold | 705.41K | 672.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 34.14% | 14.48% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 1.36M | 3.97M | 2.92M | 3.82M | 4.52M | 4.31M | 3.84M | 6.3M | 4.45M | 3.28M | 1.37M | 1.24M |
| Gross Margin % | 65.86% | 85.52% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -69.88% | -7.79% | -24.15% | -39.46% | 1.55% | 31.15% | 180.51% | 407.24% | 538.45% | 171.18% | 54.28% | 20.8% |
| Operating Expenses | 15.23M | 13.01M | 14.2M | 16.07M | 15.34M | 14.39M | 12.56M | 9.9M | 12.53M | 9.55M | 8.76M | 10.05M |
| OpEx % of Revenue | 737.24% | 280.16% | 487.1% | 420.91% | 339.35% | 334.06% | 326.8% | 157.1% | 281.46% | 290.86% | 639.49% | 808.85% |
| Selling, General & Admin | 3.21M | 3.18M | 3.12M | 4.82M | 3.23M | 3.91M | 3.28M | 3.01M | 3.45M | 4.75M | 3.31M | 4.14M |
| SG&A % of Revenue | 155.34% | 68.52% | 107% | 126.17% | 71.56% | 90.85% | 85.43% | 47.79% | 77.57% | 144.64% | 241.97% | 333.47% |
| Research & Development | 12.02M | 9.83M | 11.08M | 11.41M | 12.32M | 10.61M | 9.41M | 7.05M | 9.28M | 7.73M | 5.45M | 5.91M |
| R&D % of Revenue | 581.9% | 211.65% | 380.1% | 298.87% | 272.69% | 246.37% | 244.96% | 111.78% | 208.61% | 235.48% | 397.52% | 475.38% |
| Other Operating Expenses | 0 | 0 | 0 | -158K | -222K | -136K | -138K | -156K | -210K | -1000K | 0 | 1 |
| Operating Income | -13.87M | -9.04M | -11.28M | -12.25M | -10.82M | -10.08M | -8.72M | -3.6M | -8.07M | -6.27M | -7.39M | -8.81M |
| Operating Margin % | -671.37% | -194.65% | -387.1% | -320.91% | -239.34% | -234.06% | -226.8% | -57.1% | -181.46% | -190.86% | -539.49% | -708.85% |
| Operating Income Growth % | -28.27% | 10.33% | -29.46% | -240.25% | -33.94% | -60.83% | -17.93% | 59.14% | 14% | 49.7% | 62.71% | 44.35% |
| EBITDA | -13.17M | -8.37M | -10.61M | -11.57M | -10.14M | -9.41M | -8.03M | -2.89M | -7.38M | -5.54M | -6.75M | -8.22M |
| EBITDA Margin % | -637.24% | -180.16% | -364.08% | -303.22% | -224.34% | -218.48% | -208.9% | -45.82% | -165.93% | -168.7% | -492.63% | -661.06% |
| EBITDA Growth % | -29.89% | 11.09% | -32.2% | -300.62% | -37.3% | -69.86% | -18.95% | 64.84% | 16.47% | 54.83% | 64.87% | 46.09% |
| D&A (Non-Cash Add-back) | 705.41K | 672.63K | 671K | 675K | 678K | 671K | 688K | 711K | 691K | 728K | 642K | 594K |
| EBIT | -13.87M | -9.04M | -11.01M | -12.25M | -10.82M | -6.49M | -8.85M | -3.6M | -8.07M | -1.02M | -7.39M | -8.81M |
| Net Interest Income | 215.49K | 117.88K | 0 | 192K | 455K | 704K | 469K | 513K | 488K | 1.1M | 363K | 470K |
| Interest Income | 215.49K | 117.88K | 0 | 192K | 455K | 704K | 469K | 515.59K | 490.87K | 824.29K | 373.56K | 468.97K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.59K | 2.87K | -276.71K | 10.56K | -1.03K |
| Other Income/Expense | 270.37K | 204.07K | 278K | 88K | 737K | 776K | 608K | 708K | 420K | 790K | 2.01M | 876K |
| Pretax Income | -13.6M | -8.84M | -11.01M | -12.16M | -10.08M | -9.3M | -8.11M | -2.89M | -7.66M | -5.48M | -5.38M | -7.94M |
| Pretax Margin % | -658.29% | -190.25% | -377.56% | -318.6% | -223.04% | -216.04% | -210.98% | -45.87% | -172.02% | -166.81% | -392.63% | -638.38% |
| Income Tax | 0 | 991 | 0 | 18K | 0 | 0 | 0 | -200K | 3K | 5K | 41K | 42K |
| Effective Tax Rate % | 0% | -0.01% | 0% | -0.15% | 0% | 0% | 0% | 6.92% | -0.04% | -0.09% | -0.76% | -0.53% |
| Net Income | -13.6M | -8.84M | -11.01M | -12.18M | -10.08M | -9.3M | -8.11M | -2.69M | -7.66M | -5.48M | -5.71M | -7.99M |
| Net Margin % | -658.29% | -190.27% | -377.56% | -319.07% | -223.04% | -216.04% | -210.98% | -42.7% | -172.09% | -166.96% | -416.79% | -643.04% |
| Net Income Growth % | -34.96% | 5.04% | -35.74% | -352.41% | -31.61% | -69.71% | -42% | 66.32% | 14.27% | 58.77% | 75.51% | 41.66% |
| Net Income (Continuing) | -13.6M | -8.84M | -11.01M | -12.18M | -10.08M | -9.3M | -8.11M | -2.69M | -7.66M | -5.48M | -5.42M | -7.98M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -290K |
| EPS (Diluted) | -0.13 | -0.09 | -0.10 | -0.12 | -0.10 | -0.11 | -0.10 | -0.03 | -0.09 | -0.07 | -0.07 | -0.10 |
| EPS Growth % | -30% | 22.64% | -0.7% | -263.64% | -5.93% | -61.53% | -40.85% | 66.6% | 4.45% | 51.36% | 79.26% | 52.95% |
| EPS (Basic) | -0.13 | -0.09 | -0.10 | -0.12 | -0.10 | -0.11 | -0.10 | -0.03 | -0.09 | -0.07 | -0.07 | -0.10 |
| Diluted Shares Outstanding | 105.36M | 103.01M | 110.06M | 105.34M | 105.3M | 81.67M | 81.67M | 81.67M | 81.57M | 78.46M | 81M | 80.94M |
| Basic Shares Outstanding | 105.36M | 103.01M | 105.35M | 105.34M | 105.3M | 81.67M | 81.67M | 81.67M | 81.57M | 78.46M | 81M | 80.94M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |